ARTICLE | Company News
Kite Pharma, National Institutes of Health deal
October 22, 2012 7:00 AM UTC
NIH's National Cancer Institute granted Kite exclusive access to current and future engineered peripheral blood autologous T cell therapeutics to treat hematological and solid cancers. Kite will also ...